Showing 1 - 10 of 9,439
We model a duopoly in which ex ante identical firms must decide where to direct their innovation efforts. The firms … face market uncertainty about consumers' preferences for innovation on two product attributes and technology uncertainty … market research always attempts innovation on the attribute it discovers that consumers prefer and expends more on R&D than a …
Persistent link: https://www.econbiz.de/10008787887
production. It marks out the leading role of pharmacy in the world innovation and investment processes. It considers the …
Persistent link: https://www.econbiz.de/10010855971
В статье рассмотрены основные факторы, свидетельствующие о значении мировой фармацевтической отрасли в глобальной экономике. Показаны общий объем мирового...
Persistent link: https://www.econbiz.de/10011226478
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …
Persistent link: https://www.econbiz.de/10008693155
Indian pharmaceutical industry is one of the fastest growing sectors of Indian economy but the medicines we take suffer from serious ills: they are not stored and transported the way they ought to be. Pharmaceutical companies face issues related to choosing and working with the right logistics...
Persistent link: https://www.econbiz.de/10010668805
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry …. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the … right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …
Persistent link: https://www.econbiz.de/10005699264
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276